Trial
NCT05237284
Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Sanofi
Collaborators
—
Condition
Amyotrophic Lateral Sclerosis
Intervention
SAR443820
Why stopped
The study was terminated as its Part A did not meet the primary endpoint.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-21